Rising complaints of unauthorized Obamacare plan-switching and sign-ups trigger concern

FHS
April 8, 2024
11:20 am

Federal and state regulators aren’t doing enough to stop the growing problem of rogue health insurance brokers making unauthorized policy switches for Affordable Care Act policyholders, say consumers.

Novartis reportedly in talks to buy MorphoSys; Astellas cuts PhII program; Silence’s $120M private placement

Plus, news about Adverum, BridgeBio Pharma, Vaxcyte, Corbus and Immunocore: Novartis reportedly in deal talks with MorphoSys: The Swiss Big Pharma is in advanced talks

February 6, 2024

Sangamo signs agreement with Prevail to study AAV capsids

Prevail will perform in vitro and in vivo studies on some of the adeno-associated virus capsids of Sangamo. Credit: Kateryna Kon/Shutterstock.com. Sangamo Therapeutics has signed

July 18, 2023

Immunic to Participate in Scientific Conferences in October – Biotech Investments

Issuer: Immunic, Inc. / Key word(s): Conference 04.10.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate

October 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.